339 related articles for article (PubMed ID: 15182142)
1. Prescriptions and dosages of anti-tuberculosis drugs in the National Tuberculosis Control Programme of Malawi.
Harries AD; Gausi F; Salaniponi FM
Int J Tuberc Lung Dis; 2004 Jun; 8(6):724-9. PubMed ID: 15182142
[TBL] [Abstract][Full Text] [Related]
2. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
[TBL] [Abstract][Full Text] [Related]
3. Decentralisation of treatment for patients with tuberculosis in Malawi: moving from research to policy and practice.
Salaniponi FM; Gausi F; Mphasa N; Nyirenda TE; Kwanjana JH; Harries AD
Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S38-47. PubMed ID: 12971653
[TBL] [Abstract][Full Text] [Related]
4. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
5. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
Migliori GB; Espinal M; Danilova ID; Punga VV; Grzemska M; Raviglione MC
Int J Tuberc Lung Dis; 2002 Oct; 6(10):858-64. PubMed ID: 12365571
[TBL] [Abstract][Full Text] [Related]
6. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
Ahn HC; Lee YC
Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical formulation of a fixed-dose anti-tuberculosis combination.
Danckwerts MP; Ebrahim S; Pillay V
Int J Tuberc Lung Dis; 2003 Mar; 7(3):289-97. PubMed ID: 12661846
[TBL] [Abstract][Full Text] [Related]
8. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
Shah AR; Agarwal SK; Shah KV
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
[TBL] [Abstract][Full Text] [Related]
9. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
Dekker TG; Lötter AP
Int J Tuberc Lung Dis; 2003 Mar; 7(3):205-6. PubMed ID: 12661831
[No Abstract] [Full Text] [Related]
10. Management and outcome of tuberculosis patients who fail treatment under routine programme conditions in Malawi.
Harries AD; Nyirenda TE; Kemp JR; Squire BS; Godfrey-Faussett P; Salaniponi FM
Int J Tuberc Lung Dis; 2003 Nov; 7(11):1040-4. PubMed ID: 14598962
[TBL] [Abstract][Full Text] [Related]
11. Auditing the new decentralised oral treatment regimens in Malawi.
Nyirenda TE; Harries AD; Gausi FK; Ito K; Kemp JR; Squire BS; Godfrey-Faussett P; Salaniponi FM
Int J Tuberc Lung Dis; 2004 Sep; 8(9):1089-94. PubMed ID: 15455593
[TBL] [Abstract][Full Text] [Related]
12. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
Wilkinson D; Bechan S; Connolly C; Standing E; Short GM
Int J Tuberc Lung Dis; 1998 Jan; 2(1):52-5. PubMed ID: 9562111
[TBL] [Abstract][Full Text] [Related]
13. [Long-term efficacy of full course intermittent short-course chemotherapy on new smear positive tuberculosis patients].
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Jun; 20(3):164-6. PubMed ID: 10072822
[TBL] [Abstract][Full Text] [Related]
14. Side-effects of drugs used in directly observed treatment short-course in newly diagnosed pulmonary tuberculosis subjects in Nigerians: a controlled clinical study.
Dosumu EA
Niger Postgrad Med J; 2002 Mar; 9(1):34-7. PubMed ID: 11932759
[TBL] [Abstract][Full Text] [Related]
15. [The results of retreatment of pulmonary tuberculosis using a short 6-month protocol 1985-1991 in the pneumo-phthisiology department of the Point G hospital in Bamako].
Kayantao D; Keïta B; Sangaré S
Bull Soc Pathol Exot; 1997; 90(2):124-7. PubMed ID: 9289251
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
17. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
Kononets AS
Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326
[TBL] [Abstract][Full Text] [Related]
18. [Antitubercular chemotherapy].
Jouveshomme S; Dautzenberg B
Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a unified treatment regimen for all new cases of tuberculosis using guardian-based supervision.
Banerjee A; Harries AD; Mphasa N; Nyirenda TE; Veen J; Ringdal T; Van Gorkom J; Salaniponi FM
Int J Tuberc Lung Dis; 2000 Apr; 4(4):333-9. PubMed ID: 10777082
[TBL] [Abstract][Full Text] [Related]
20. [Effects of intermittent short-course chemotherapy under full-course supervision on the treatment of smear positive pulmonary tuberculosis].
Yan S; Ye H; Lin S
Zhonghua Jie He He Hu Xi Za Zhi; 1996 Apr; 19(2):104-6. PubMed ID: 9388851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
